← brief for 2026-08-26 · Slowing decline

Emerging therapies for diabetic kidney disease: beyond SGLT2 inhibitors.

Article No results yet Peer reviewed

Key takeaways

A review of the next wave of drugs for kidney disease caused by diabetes, looking past the two treatments already in wide use: blood pressure drugs that act on the renin-angiotensin system, and SGLT2 inhibitors. Even with both, many people keep losing kidney function, and this article covers the new drugs being built to close that gap. It is a summary of the field written by experts, not a trial. There are no new results in it.

Who did this work

Ni H · Piggott S · Festa MC · Faruque L · Cherney DZI

Source

Article · PubMed, the drug frontier · 2026 Aug 24
https://pubmed.ncbi.nlm.nih.gov/42638087/